Procos releases new brochure and APIs catalog
Press Release | Procos S.p.A.
APRIL 28, 2016
Cameri, Italy: – Leading Italian contract manufacturer (CMO) Procos has applied its ‘green and grey’ brand identity, seen on its website, to its redesigned downloadable brochure and APIs catalog.
The new assets harmonize with the company’s new look website, featuring the same house colors of charcoal and green, with redesign to provide clearer navigation and enhanced usability.
The revised API list features clearly laid out presentation of each product by structure formula, product name, catalog CAS number, therapeutic class and available drug master files (DMFs). It can be browsed online or easily downloaded from the Procos website (see Resources).
The new brochure will be shared with Procos customers at upcoming tradeshows, including CPHI Japan, CPHI China, CPHI Barcelona and CPHI India, as well as during special events like the Scientific update conference and tours of Procos headquarters and new manufacturing facility in Cameri.
Procos S.p.A. is an Italian Contract Research and Manufacturing Organization (CRO, CMO) that specializes in development, scale-up and production of APIs and cGMP advanced intermediates for the pharmaceutical industry.
Procos is an important member of the international CBC Group, headquartered in Japan. This network provides Procos with global reach, reinforced with subsidiary sales offices in the USA, Slovakia, Germany and India.
Over seven decades, Procos has built up a comprehensive range of technologies and capabilities to provide high quality products and services that have been widely accepted in worldwide pharmaceutical markets. It continuously develops and adds unique generic APIs and key intermediates to its product portfolio.
Procos’ two core business sectors are the development and supply of APIs and GMP advanced intermediates along with contract manufacturing services.
Procos manufactures more than 30 products, mostly under uniquely designed synthetic methods and under strict regulatory compliance management. In contract manufacturing, Procos provides related services for the pharmaceutical industry acting as a CRO/CMO for custom synthesis on exclusive base, supporting customer from early clinical stage up to full -scale commercial production. Development services include IP analysis expertise and effective patent challenge skills.
Innovation is a driving force of Procos activity. The company’s products are based on patented technologies and cost-effective processes. Procos chemistry expertise is focused on the most complex organic reactions, including organo-metallic catalysis, multi-catalytic hydrogenation, Enantio selective and hazardous chemistry.
Kingo Yamashita, Sales & Marketing Director, Procos SpA
Tel: +39 0321 642211
Click on Procos releases new brochure and APIs catalog for other information.
Click on Procos to contact the company directly.
Click on New Procos online brochure for more information.
Click on Catalog to see new APIs product list .